Liz Claiborne, Inc. (NYSE:LIZ) has gained 2.03% or $.11 to settle at $5.52 with a volume of 920,000 shares. For the past 52 weeks the stock has been trading between $3.90 and $9.72 with an average volume of 3.49 million shares. Company has a market cap of $521 million and a beta of 2.15.
Liz Claiborne, Inc., incorporated in January 1976, designs and markets a global portfolio of retail-based brands, including JUICY COUTURE, KATE SPADE, LUCKY BRAND and MEXX. The Company also has a group of department store-based brands with consumer franchises, including the LIZ CLAIBORNE and MONET families of brands, MAC & JAC, KENSIE and DANA BUCHMAN and the licensed DKNY JEANS, DKNY ACTIVE and DKNY MENS brands.
International Rectifier Corporation (NYSE:IRF) has gained 2.97% or $.97 to settle at $30.67 with a volume of 563,000 shares. For the past 52 weeks the stock has been trading between $32.64 and $34.06. Company has a market capitalization of $2.35 billion and a beta of 1.33.
International Rectifier Corporation (IR) designs, manufactures and markets power management semiconductors. The Company's products include power metal oxide semiconductor field effect transistors (MOSFETs), high voltage analog and mixed signal integrated circuits (HVICs), low voltage analog and mixed signal integrated circuits (LVICs), digital integrated circuits (ICs), radiation-resistant (RAD-Hard) power MOSFETs, insulated gate bipolar transistors (IGBTs), high reliability direct current to direct current (DC-DC) converters and automotive product packages.
IAMGOLD (NYSE:IAG) has lost 1.5% or $.32 a share to settle at $21.65 with a volume of 1.7 million shares. For the past 52 weeks the stock has been trading between $21.41 and $21.89 with an average volume of 2.7 million shares. Company has a market capitalization of $8.07 billion with a beta of 0.5.
IAMGOLD Corporation (IAMGOLD) is a Canada-based mining and exploration company. IAMGOLD's interests include seven operating gold mines and a niobium producer, a diamond royalty, and exploration and development projects located throughout Africa and the Americas.
Curtiss-Wright Corp. (NYSE:CW) has gained 2.57% or $.96 to settle at $30.31 a share with a volume of 90,800. For the past 52 weeks the stock has been trading between $37.20 and $38.36. Company has a market cap of $1.77 billion and a beta of 1.27.
Curtiss-Wright Corporation designs and manufactures highly engineered, advanced technologies that perform critical functions in the defense, energy, commercial aerospace and general industrial markets. Its general industrial markets include metallurgical services for automotive, construction, marine, simulation and test equipment. It has three segments.
Apricus Bioscience Inc. (NASDAQ:APRI) has gained 1.18% or six cents a share to settle at $5.17 with a volume of 690,000 shares. For the past 52 weeks the stock has been trading between $4.63 and $5.25 with an average volume of 850,000 shares. Company has a market cap of 66 million shares.
Apricus Biosciences, Inc., formerly NexMed, Inc., is a pharmaceutical research and development company focused on the design and development of products and technologies in multiple therapeutic areas, including oncology, sexual dysfunction, autoimmune diseases and pain/inflammation. Its drug delivery technology is called NexACT.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCpicks.com has not been compensated for any current or recent stocks listed in this stock news report
